ESC 365 - Impact of frailty status on 30-day mortality in patients with valvular heart disease undergoing percutaneous transcatheter valve interventions

ESC Premium Access

Impact of frailty status on 30-day mortality in patients with valvular heart disease undergoing percutaneous transcatheter valve interventions

Session: Poster Session 4 - Non-coronary cardiac intervention

Topic: Aortic Valve Intervention

Speaker: Assistant Professor B. Al-Kassou (Bonn, DE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Assistant Professor Baravan Al-Kassou

University hospital Bonn, Bonn (Germany)

2 presentations

2 followers

15 more presentations in this session

Myocardial injury during TAVI with self-expanding prosthesis is not associated with patient-prosthesis features, hemodynamics or clinical outcome

Speaker: Doctor M. Johnsen (Oslo, NO)

Cerebral near-infrared spectroscopy monitoring during transcatheter aortic valve implantation

Speaker: Doctor P. Seppelt (Frankfurt, DE)

Clinical and echocardiographic outcomes after treatment of patent foramen ovale with two transcatheter occlusion devices: mononcenter observational study

Speaker: Mr M. Alsaad (Bielefeld, DE)

Platelet reactivity changes following transcatheter aortic valve implantation

Speaker: Doctor Z. Ostojic (Zagreb, HR)

Impact of chronic kidney disease on efficacy and safety of interventional left atrial appendage closure - Results from the prospective multicenter LAARGE registry

Speaker: Doctor C. Fastner (Mannheim, DE)

Access the full session

Poster Session 4 - Non-coronary cardiac intervention

Speakers: Assistant Professor B. Al-Kassou, Doctor M. Johnsen, Doctor P. Seppelt, Mr M. Alsaad, Doctor Z. Ostojic...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources